Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study

In 2021–2022, influenza A viruses dominated in Europe. The I‐MOVE primary care network conducted a multicentre test‐negative study to measure influenza vaccine effectiveness (VE).

[1]  D. Skowronski,et al.  Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  S. de Lusignan,et al.  Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  F. Pozo,et al.  Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  Amanda Bolt Botnen,et al.  A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  Aman Verma,et al.  Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  L. Brammer,et al.  Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[7]  Aman Verma,et al.  Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors , 2021, medRxiv.

[8]  M. Valenciano,et al.  Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  F. Pozo,et al.  Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019. , 2020, Vaccine.

[10]  M. Valenciano,et al.  Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  M. Valenciano,et al.  Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18) , 2019, Vaccine: X.

[12]  M. Valenciano,et al.  2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children , 2018, Influenza and other respiratory viruses.

[13]  B. Flannery,et al.  Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015 , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  U. Buchholz,et al.  I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  S. Hensley,et al.  Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. , 2014, Current opinion in virology.

[16]  U. Buchholz,et al.  Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  J. Plotkin,et al.  Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.

[18]  Jennifer C Nelson,et al.  The test-negative design for estimating influenza vaccine effectiveness. , 2013, Vaccine.

[19]  D. Fleming,et al.  Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  M. Valenciano,et al.  Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  M. Valenciano,et al.  I-MOVE: a European network to measure the effectiveness of influenza vaccines. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  M. Valenciano,et al.  I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe , 2011, PloS one.

[23]  M. Valenciano,et al.  Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study , 2011, PLoS medicine.

[24]  M. Valenciano,et al.  "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[25]  Xiaolin Zhang,et al.  EFFECTIVENESS , 1977, Prospects for Constitutionalism in Post-Communist Countries.

[26]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[27]  Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season. , 2012, Releve epidemiologique hebdomadaire.

[28]  Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season. , 2011, Releve epidemiologique hebdomadaire.